Ozempic is approved only for treating Type 2 diabetes but claims about its weight-loss powers have seen demand soar, ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved ... According to Chinese business news ...

For years, Miriam Schulman of Highland Park, New Jersey, struggled with what she called ‘food noise.’ “You’re always thinking ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

How do you like to unwind at night, before switching off the bedroom lamp and going to sleep? A couple of chapters of a ...

Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

The weight loss drug boom is here, and even retailers like Walmart are starting to feel the pressure to compete.

Although it is administered via injection, rather than in pill form, early results show a 200% higher weight loss reduction ...

As GLP-1 drugs like Ozempic soar in popularity for weight loss, this film follows three people on their own GLP-1 journeys and explores how decades of diet culture and society’s relentless pursuit of ...

The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...

Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...